Search Results - "Das, Sonia G"
-
1
A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer
Published in Pharmaceutics (01-04-2024)“…New targeted treatments are urgently needed to improve triple-negative breast cancer (TNBC) patient survival. Previously, we identified the cell surface…”
Get full text
Journal Article -
2
A Facile Asymmetric Synthesis of Either Enantiomer of 2-Substituted Pyrrolidines
Published in Journal of organic chemistry (02-04-2010)“…A new and general method for asymmetric synthesis of either enantiomer of 2-substituted pyrrolidines from a single starting material is described. Reductive…”
Get full text
Journal Article -
3
Overexpression of Mcl-1 confers multidrug resistance, whereas topoisomerase IIβ downregulation introduces mitoxantrone-specific drug resistance in acute myeloid leukemia
Published in Molecular pharmacology (01-08-2013)“…Drug resistance is a serious challenge in cancer treatment and can be acquired through multiple mechanisms. These molecular changes may introduce varied…”
Get more information
Journal Article -
4
miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells
Published in Breast cancer research : BCR (02-04-2016)“…ADAM8 (a disintegrin and metalloproteinase 8) protein promotes the invasive and metastatic phenotype of triple-negative breast cancer (TNBC) cells. High ADAM8…”
Get full text
Journal Article -
5
Putative Identification of New Phragmaline-Type Limonoids from the Leaves of Swietenia macrophylla King: A Case Study Using Mass Spectrometry-Based Molecular Networking
Published in Molecules (Basel, Switzerland) (01-11-2023)“…Swietenia macrophylla King is a plant commonly known as Brazilian mahogany. The wood from its stem is highly prized for its exceptional quality, while its…”
Get full text
Journal Article -
6
Structure–Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and Its Analogues
Published in Journal of medicinal chemistry (25-08-2011)“…Multidrug resistance (MDR) in cancer is a phenomenon in which administration of a single chemotherapeutic agent causes cross-resistance of cancer cells to a…”
Get full text
Journal Article -
7
Structure−Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4H-chromene-3-carboxylate (sHA 14-1) and Its Analogues
Published in Journal of medicinal chemistry (08-10-2009)“…Rapid development of multiple drug resistance against current therapies is a major barrier in the treatment of cancer. Therefore, anticancer agents that can…”
Get full text
Journal Article -
8
Untargeted-based metabolomics analysis and in vitro/in silico antiviral activity of extracts from Phyllanthus brasiliensis (Aubl.) Poir
Published in Phytochemical analysis (01-10-2023)“…This study describes the molecular profile and the potential antiviral activity of extracts from Phyllanthus brasiliensis, a plant widely found in the…”
Get full text
Journal Article -
9
sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell
Published in Cancer letters (08-02-2008)“…Abstract HA 14-1, a small-molecule antagonist against anti-apoptotic Bcl-2 proteins, was demonstrated to induce selective cytotoxicity toward malignant cells…”
Get full text
Journal Article -
10
Ethyl 2‑Amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)‑4H‑chromene-3-carboxylate (CXL017): A Novel Scaffold That Resensitizes Multidrug Resistant Leukemia Cells to Chemotherapy
Published in ACS chemical biology (15-02-2013)“…Multidrug resistance (MDR) is a major hurdle in the treatment of cancer, and there is a pressing need for new therapies. We have recently developed ethyl…”
Get full text
Journal Article -
11
Abstract 23: Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Triple-Negative Breast Cancer (TNBC) accounts for 25% of breast cancer deaths. Current therapeutic options are restricted to chemotherapy (CT) and…”
Get full text
Journal Article -
12
Abstract 6639: SRF617, a potent enzymatic inhibitor of CD39, demonstrates single-agent activity and cooperates with various cancer therapies in both solid tumor and hematologic malignancies
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract CD39 (ENTPD1) is a key enzyme responsible for the degradation of extracellular adenosine triphosphate (ATP) and is upregulated in the tumor…”
Get full text
Journal Article -
13
Abstract 1137: ADAM8 drives aggressive phenotype of triple-negative inflammatory breast cancer & constitutes a novel therapeutic target
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Inflammatory Breast Cancer (IBC) is a rare, highly aggressive form of cancer that is frequently locally advanced or metastasized at the time of…”
Get full text
Journal Article -
14
-
15
Characterization of a tetrameric proanthocyanidin in Stryphnodendron pulcherrimum and an overview on potential health benefits of condensed tannins via interaction with gut microbiota
Published in Journal of functional foods (01-10-2023)“…[Display omitted] •A tetrameric condensed tannin of (epi)catechin-(epi)gallocatechin was described for the first time in the barks from Stryphnodendron…”
Get full text
Journal Article -
16
Abstract B166: MicroRNAs downstream of ADAM8 as therapeutic targets and non-invasive biomarkers for triple-negative breast cancer
Published in Molecular cancer therapeutics (01-11-2013)“…Abstract Triple-negative breast cancer (TNBC) represents ∼20% of breast cancers, is highly aggressive and lacks targeted therapies due to the absence of…”
Get full text
Journal Article -
17
Ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) – a novel scaffold that re-sensitizes multidrug resistant leukemia cells to chemotherapy
Published in ACS chemical biology (05-11-2012)“…Multidrug resistance (MDR) is a major hurdle in the treatment of cancer and there is a pressing need for new therapies. We have recently developed ethyl…”
Get full text
Journal Article -
18
-
19
-
20
Putative Identification of New Phragmaline-Type Limonoids from the Leaves of ISwietenia macrophylla/I King: A Case Study Using Mass Spectrometry-Based Molecular Networking
Published in Molecules (Basel, Switzerland) (01-11-2023)“…Swietenia macrophylla King is a plant commonly known as Brazilian mahogany. The wood from its stem is highly prized for its exceptional quality, while its…”
Get full text
Journal Article